Sort
40,608 grants matching “prostate cancer”
Inhibiting serine protease-induced prostate cancer progression
$316,213Evette S Radisky · Mayo Clinic Jacksonville · R01 · FY2014 · CA
Developmental Core
$316,205Warren Jackson Pledger · H. Lee Moffitt Cancer Ctr & Res Inst · U56 · FY2010 · CA
Photonic Nanosonophores for Functional and Structural Imaging
$316,169Raoul Kopelman · University Of Michigan At Ann Arbor · R01 · FY2018 · CA
Role of EZH2 in Epithelial Ovarian Cancer
$316,168Rugang Zhang · Wistar Institute · R01 · FY2012 · CA
Mechanisms of Progression in Oncogene-Incuded Prostate Cancer
$316,164Timothy C Thompson · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
PSMA, a Nutritional Target for Prostate Cancer Preventi*
$316,136Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2004 · CA
PSMA, a Nutritional Target for Prostate Cancer Preventi*
$316,136Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2005 · CA
Genetic Analysis of Hereditary Prostate Cancer Families
$316,107University Of Michigan At Ann Arbor · R01 · FY2005 · CA
Therapeutics of XIAP Degradation by Zinc Chelators
$316,103Vladimir M Kolenko · Fox Chase Cancer Center · R01 · FY2011 · CA
Next generation bisphosphonates for chemo- and immuno-therapy
$316,099Eric Oldfield · University Of Illinois At Urbana-Champaign · R01 · FY2012 · CA
Next generation bisphosphonates for chemo- and immuno-therapy
$316,099Eric Oldfield · University Of Illinois At Urbana-Champaign · R01 · FY2015 · CA
Novel Inhibitors of Prostate Cancer Progression
$316,081Ajit K Verma · University Of Wisconsin-Madison · R01 · FY2013 · CA
Statewide Cancer Data
$316,072Andrew Olshan · Univ Of North Carolina Chapel Hill · P30 · FY2025 · CA
Core B: Biospecimen and Pathology
$316,067Colm M Morrissey · Fred Hutchinson Cancer Center · P50 · FY2023 · CA
NEUTRAL ENDOPEPTIDASE INACTIVATION IN ADVANCED PROSTATE
$316,044Weill Medical College Of Cornell Univ · R01 · FY2001 · CA
MicroRNAs in differentiation of muscle
$316,020Anindya Dutta · University Of Virginia · R01 · FY2010 · AR
Bone metabolism and bone metastases in prostate cancer
$316,003Kathryn M. Wilson · Harvard School Of Public Health · R01 · FY2014 · CA
Control of TGF-Beta/Smad Signaling by mTOR in Prostate Cancer
$316,002David Danielpour · Case Western Reserve University · R01 · FY2012 · CA
Characterizing the DNA methylomes of indolent and aggressive prostate cancers
$316,002Angela H Ting · Cleveland Clinic Lerner Com-Cwru · R01 · FY2014 · CA
EphA2 kinase in prostate cancer
$316,002Bingcheng Wang · Case Western Reserve University · R01 · FY2014 · CA
Bone Marrow MSCs/Pericytes: Gatekeepers Controlling Skeletal Metastasis.
$316,002Arnold I. Caplan · Case Western Reserve University · R01 · FY2014 · CA
Control of TGF-Beta/Smad Signaling by mTOR in Prostate Cancer
$316,002David Danielpour · Case Western Reserve University · R01 · FY2011 · CA
Bootstrap-based testing of rare sequence variants using family data
$316,002Alice S Whittemore · Stanford University · R01 · FY2014 · CA
Quality of Life of Older Adult Long-Term Cancer Survivor
$315,991Gary T Deimling · Case Western Reserve University · R01 · FY2006 · CA
Core C: Pathology, Biospecimen and Immune Profiling
$315,977Tamara Levin Lotan · University Of Southern California · U19 · FY2019 · CA